Financing - March 9, 2015
Novo’s IT Shares on the Rise
On its first day on the Copenhagen stock market Friday, Novo Nordisk’s newly public IT business got off to a fast start, with shares rising by as much as 44 percent, according to Reuters. Investors quickly bid up shares in NNIT, which had an offering price of 125 Danish kroner, or about $18—a figure analysts […]
Pharma Business - September 2, 2014
Novo creates investment unit
Novo Nordisk’s holding company Novo A/S is setting up a new unit for major acquisitions that can invest ten billion DKK annually, according to web magazine News Øresund. The ambition is to buy companies within the pharmaceutical, biotech and medtech sector in the Nordic countries and other parts of Europe. “We have decided to construct […]
Acquisition - May 24, 2013
Novo A/S acquires Xellia Pharmaceuticals
Novo A/S, the holding company of the Novo Group, has purchased all shares in pharmaceutical group Xellia Pharmaceuticals for approximately USD 700 million. Xellia will now revert to Danish ownership with headquarters in Copenhagen, Denmark following the recent acquisition. Xellia Pharmaceuticals focuses on development, manufacturing and global commercialization of anti-infective therapies. Since its spin-out from Alpharma […]
